5 September 2024
Insig
AI plc
("Insig
AI" or the "Company")
Final
results for the year ended 31 March 2024
and
Posting
of the Annual Report and Accounts and Notice of Annual General
Meeting
Insig AI plc (AIM:INSG),
the data science and machine learning solutions
company and its subsidiaries (the "Group") is pleased to announce its
results for the year ended 31 March 2024.
The Group's Annual Report &
Accounts, along with the Company's Notice of Annual General Meeting
("AGM") will be posted to shareholders today and will be available
shortly on the Group's website: www.insg.ai/investor-relations/. The
AGM will be held at 1 Heddon Street, London, W1B 4BD on 30
September 2024 at 12:30 p.m.
Highlights
· Reduced adjusted EBITDA loss of £0.6 million from £2 million
in the previous year
· Recognised by the FCA as a key contributor in its
anti-greenwashing technology initiative
· New
product launch of the Transparency and Disclosure Index
· In
discussions with three of 'The Big Four' Accounting
Practices
· In
discussions with UK asset manager regarding partnering on a new
fund launch
· Visibility of regulatory tailwinds
Richard Bernstein, CEO
commented: "After
a two year wait, we finally have visibility of regulatory tailwinds
that should represent the compelling event in the nascent market of
non-financial corporate disclosures. We are ideally positioned to
benefit. Alongside our capabilities to structure data for clients
to utilise AI, with improved execution, the coming months are set
to bear fruit from our substantial investment."
For further information, please
visit www.insg.ai or contact:
Insig AI
plc
richard.bernstein@insg.ai
Richard Bernstein
(CEO)
Zeus (Nominated Adviser &
Broker)
David Foreman / James Hornigold
+44 (0)20 3829 5000
Chief Executive's
Report
Dear Shareholders,
It is now three months since I
became Chief Executive. I am also delighted that John Wilson has
become Chairman. Set out below is my assessment of the performance
of the business during the year ended 31 March 2024, together with
an update on recent progress and of prospects. First, let me turn
to the year ended 31 March 2024.
Financial headlines
In summary, we are reporting an
operating loss before non-cash impairments of intangible assets of
£2.2 million. This compares with an operating loss prior to
impairment for the previous year of £4.8 million. Within the loss
for the year, the non-cash expense of depreciation and amortisation
was £1.6 million, resulting in an operating loss of £0.6 million
prior to these non-cash charges. The equivalent loss for the
previous year was £2.0 million.
Revenues for the year were £0.4
million as against £0.7 million in the year to March
2023.
The financial results reflect not
only trading but some accounting standard led treatments of
intangible assets, and loan notes which have a distorting impact on
the optics of the results in my view. As I set out below, the
financial year ended 31 March 2024 as well as the current financial
year to date, represents a period of progress, right-sizing of the
business and pleasingly, significantly improved relationships with
several hopefully long term and significant prospective partners of
Insig. Frustratingly however, these developing relationships did
not yield significant revenues in the financial year ended 31 March
2024.
Following the conversion of £0.75
million of loan notes into equity, outstanding convertible loan
notes reduced from £2.3 million to £1.5 million as at 31 March
2024.
Disposal of Sports in Schools Limited and The Elms Group
Limited
Sports in Schools and Elms Group
combined generated a profit before tax of approximately £210,085
(2023: £19,000). In November 2023, the Company's 85.87% owned
subsidiary, Pantheon Leisure plc ("Pantheon"), entered into a sale
agreement for Sports in Schools and Elms Group with Haygreen
Limited for a total cash consideration payable of £0.3 million (the
"Cash Consideration"). The joint profit before tax for Sport in
Schools and Elms Group up to November 2023 was.
The directors of Pantheon Leisure
plc, which previously held the Group's interest in Sports in
Schools, have decided to proceed with striking off the company. The
company no longer conducts any form of trade, has no recoverable
assets or funds. Therefore, the Directors believe it appropriate to
apply for strike off under s1003 of the Companies Act 2006.
The Directors consider that the strike off proposal is in the best
interests of the Company and its Shareholders as a whole. This will
result in a reduction in legal and administrative costs.
In November 2023, I agreed to
release security over my loan of £0.75 million to the Company and I
converted the loan plus accumulated interest into 3,925,380
ordinary shares at 20p per share.
Successful equity funding
In April 2023, the Company
announced that it had completed an equity subscription raising £0.9
million at 17p per share, and as part of which, I subscribed for
£0.15 million.
Post period end, in April and May
2024, I subscribed to the Company for 1,250,000 shares at 20p. In
June 2024, the Company successfully raised £0.81 million at 12.5p
per share, with NR Holdings Limited becoming a new
shareholder.
The report card for the year to 31 March
2024
In the first few months of the
year under review, much of our resources were focussed on our data
and technology collaboration agreement, working with the Financial
Conduct Authority ("FCA"). In April 2023, we announced that we
would be providing the data and software platforms to the FCA's
2023 TechSprint, known as the Global Financial Innovation Network's
(GFIN) Greenwashing TechSprint. The GFIN Greenwashing TechSprint
brought together 13 international regulators.
The goal of the project was to
develop a tool or solution to help regulators tackle or mitigate
the risks of greenwashing in financial services across the globe.
The project focused on how technology, including AI and Machine
Learning, can enable regulators and supervisors to verify that
ESG-related product claims are accurate and complete and how
technology can help monitor, collate, and identify examples of
greenwashing.
Insig AI provided our data and
technology platform for onboarding of partners and participants of
the GFIN Greenwashing TechSprint. The core data set comprised our
database of pdf and machine-readable corporate financial and ESG
documents with entity mapping and sentence-level classification
against 15 ESG issues.
Our endeavour was recognised last
September, when the FCA publicly referred to Insig AI as a key
contributor.
In October 2023, we announced the
launch of The Transparency and Disclosure Index ("TDI"). Using
evidence-based analysis of more than 200 million machine readable
sentences from our corporate disclosure document repository, the
TDI demonstrates what stakeholders and market participants require:
how well a company is disclosing non-financial information and how
transparent it is. Scoring highlights gaps that are actionable for
each company to remedy.
The TDI framework is based on best
practice principles behind the convergence of reporting standards.
Reports are compared to best practice, benchmarking against peer
groups, measuring website clarity and accessibility of documents.
It highlights where the range of sustainability documents is
considered excessive and flags where companies may be over-using
certain keywords identified as being commonly used in greenwashing
without evidence and are possibly misleading. Using our search
tools and our machine learning database, users can perform a deep
dive into every aspect of a multitude of disclosures. Whist the TDI
is not seeking to accuse any company, in 2022, both Signature Bank
and Home REIT were flagging material issues in terms of very poor
transparency and disclosure.
Despite the Company's engagement
with the FCA and launching of the Transparency and Disclosure
Index, these efforts failed to translate into new business wins. As
Chief Executive, my immediate priority on appointment was to
identify why this was the case and to then implement the changes
required to be able to translate efforts into commercial
success.
In mitigation, there can be no
doubt that over the last two years, the UK asset management
industry has experienced a "bear market," with fund outflows and
consequential budgetary pressures. Against this backdrop,
investment decisions, particularly in new solutions, has become a
casualty. Secondly, until there is regulation in place that
requires certain compliance, there is no compelling event that
necessitates a spend.
There have however, been some
encouraging indicators recently that the UK asset management
industry is beginning to recover and that this will result in an
easing of budgetary constraints. Of more importance though is that
from January 2025, for EU companies with more than 250 employees,
the Corporate Sustainability Reporting Directive (CSRD) comes into
force. Penalties for non-compliance include fines (in Germany up to
5% of turnover) and prison sentences for directors of up to five
years. In the UK, the FCA's anti-greenwashing rules are already in
force. In the US, climate related risk disclosures come into effect
in January 2025.
It might be easy to attribute the
lack of new business wins to the "bear market" and the delay in
regulation. It is my assessment, this would not be accurate. "The
fault, dear Brutus, is not in our stars but in ourselves," springs
to mind. For too long, the business was engaging with people
who were not authorised to make the spending decision. Furthermore,
we could have been articulated the offering in a way that showed
the benefits to prospective customers in my opinion and we could
also have contacted a greater quantity of prospects. All these
issues have now been identified: we are establishing clear
measurable deliverables and setting specific timelines and
performance reviews to monitor progress. Conversations with
prospects are now focused solely on the benefit to that prospect,
rather than how clever the technology is. Delivering on the core
goals of the business is now fundamental. There will be further
enhancements in the coming weeks and months, including improved
marketing and new partnerships that can bring revenues by making
available our products and services to new markets.
Where we are today
Let me set out what Insig AI has
to offer. There are two distinct parts of the business. Firstly, a
vast repository of corporate reports that enables regulators,
corporates, asset managers and all market participants to access,
interrogate and compare disclosures within and between companies.
Our database uses the best of machine learning and AI tools in this
area. Secondly, our ability to provide fast, accessible AI-ready
data. Asset managers can gain insights into their holdings, manage
risk and increase alpha. Insig AI can structure and centralise data
making it secure whilst increasing the efficiency and
productivity.
When I was appointed Chief
Executive, I commented that sales cycles to large corporates for
emerging technologies can take up to 18 months. This remains the
case. The business is in detailed discussions with several
prospects and given that our offering involves AI, in some cases,
we are being told that the decision-making process involves
multiple parties within an organisation.
Some of these discussions include
a number of the Big 4 Accounting Practices. In the case of one of
those firms, we have invested significant resources, including
participating in a workshop with FTSE100 companies and been
introduced as this firm's 'AI partner'. Our offering is able to
benefit this firm's top line as well as reducing regulatory risk to
many of its clients. Our solutions ought to be a 'no brainer'.
Feedback has been very positive. However, procurement processes in
these huge enterprises are extraordinarily lengthy and complex and
lack the sense of urgency that we would expect. Whilst these
timelines are incredibly frustrating, on success, they should
convert into material, long-term substantial revenues.
Prospects
For the current year, we continue
to expect to grow revenues. As importantly, we are working to
convert ongoing discussions with potential strategic partners into
commercial agreements that will enable their customers to access
our machine learning capabilities.
Amongst these, we are now engaging
with three of the "Big 4" Accounting Practices. We are also now in
discussions with one of the "Big 3" Management Consultancy firms.
Separately, we have been approached by one of the UK's largest
financial PR advisors to assist in advising clients to comply with
the new Corporate Sustainability Reporting Directive.
We are in dialogue with a UK asset
manager with assets under management of more than £2 billion, with
a view to partnering on a new fund launch. On the data science
side, we are expecting to win a long-term contract with an asset
manager who has indicated that it wants to work with us to improve
its structured data as it rapidly expands and wins new
mandates.
As Insig AI's largest shareholder
and someone who has a track record of "skin in the game" in
effecting positive change and delivering for stakeholders, I am as
keen as any shareholder to report on tangible positive results as
soon as possible. Operating in a hitherto nascent market has
required patience.
Whether you own one share or one
million shares, you are a part owner of this business. The
legendary investor Warren Buffett has said that investors often
focus on a daily share price movement rather than on making an
objective assessment of the long-term prospects of a company and
deciding what the business might be worth in the coming
years.
I will do whatever it takes to
ensure that the business delivers on both its ideal market
positioning within corporate reporting and structured AI data and
its significant commercial potential. Victory will not be achieved
overnight: it requires thought, planning, strong execution and some
patience. I regard our success as a matter of not if but
when.
Richard Bernstein
Chief Executive Officer
5
September 2024
Consolidated statement of financial
position
|
|
|
|
Note
|
31 March
2024
£
|
31 March
2023
£
|
Non-Current Assets
|
|
|
|
Property, plant and
equipment
|
12
|
5,652
|
37,648
|
Right of Use Assets
|
13
|
-
|
28,266
|
Intangible assets
|
14
|
4,404,000
|
20,309,278
|
Investment in
subsidiaries
|
15
|
-
|
-
|
|
|
4,409,652
|
20,375,192
|
Current Assets
|
|
|
|
Trade and other
receivables
|
16
|
104,740
|
719,840
|
Cash and cash
equivalents
|
17
|
37,847
|
280,584
|
|
|
142,587
|
1,000,424
|
Total Assets
|
|
4,552,239
|
21,375,616
|
Non-Current Liabilities
|
|
|
|
Lease liabilities
|
19
|
-
|
16,868
|
Deferred tax
liabilities
|
21
|
1,101,000
|
2,586,096
|
|
|
1,101,000
|
2,602,964
|
Current Liabilities
|
|
|
|
Trade and other
payables
|
18
|
338,238
|
932,927
|
Lease liabilities
|
19
|
-
|
10,386
|
Convertible loan notes
|
20
|
1,544,324
|
2,261,769
|
|
|
1,882,562
|
3,205,082
|
Total Liabilities
|
|
2,983,562
|
5,808,046
|
|
|
|
|
Net Assets
|
|
1,568,677
|
15,567,570
|
Equity attributable to owners of the Parent
|
|
|
|
Share capital
|
23
|
3,149,058
|
3,109,804
|
Share premium
|
23
|
40,810,725
|
39,077,403
|
Other reserves
|
25
|
516,015
|
377,381
|
Share based payments
reserve
|
24
|
2,485
|
18,845
|
Retained losses
|
|
(42,880,866)
|
(26,964,846)
|
Equity attributable to shareholders of the
parent
parent company
|
|
1,597,417
|
15,618,587
|
Non-controlling
interests
|
|
(28,740)
|
(51,017)
|
Total Equity
|
|
1,568,677
|
15,567,570
|
The Company has elected to take
the exemption under Section 408 of the Companies Act 2006 from
presenting the Parent Company Income Statement and Statement of
Comprehensive Income. The loss for the Company for the year ended
31 March 2024 was £17,185,547 (31 March 2023: loss of
£21,180,437).
The Financial Statements were
approved and authorised for issue by the Board of Directors on 5
September 2024 and were signed on its behalf by:
Richard Bernstein
Chief Executive Officer
Consolidated statement of comprehensive
income
|
|
Continued operations
|
Note
|
Year ended 31 March
2024
£
|
Year ended 31 March
2023
£
|
Revenue
|
5
|
369,860
|
693,734
|
Cost of sales
|
5
|
-
|
(50)
|
Gross profit
|
|
369,860
|
693,684
|
Administrative expenses
|
7
|
(2,562,208)
|
(5,474,077)
|
Other gains/(losses)
|
9
|
(102,965)
|
(15,796)
|
Other income
|
10
|
3,160
|
-
|
Impairments
|
14
|
(15,317,338)
|
(16,558,296)
|
Operating loss
|
|
(17,609,491)
|
(21,354,485)
|
Finance income
|
11
|
263
|
101
|
Finance costs
|
11
|
(126,390)
|
(80,072)
|
Loss before income tax
|
|
(17,735,618)
|
(21,434,456)
|
Tax credit/(charge)
|
27
|
1,615,430
|
2,865,865
|
Loss for the year after income tax from continued
operations
|
|
(16,120,188)
|
(18,568,591)
|
Discontinued operations
|
|
|
|
Profit for the year from
discontinued operations (attributable to equity holders of the
Parent)
|
|
210,085
|
6,245
|
Group loss for the year
|
|
(15,910,103)
|
(18,562,346)
|
Loss for the year attributable to owners of the
Parent
|
|
(15,932,380)
|
(18,563,996)
|
Profit/(Loss) for the year attributable to Non-controlling
interests
|
|
22,277
|
1,650
|
Basic and Diluted Earnings/(Loss) Per Share (expressed in
pence per share)
|
|
|
|
Continued operations
|
|
(17.71)p
|
(17.89)p
|
Discontinued operations
|
|
0.21p
|
0.01p
|
Total
|
28
|
(17.50)p
|
(17.88)p
|
Consolidated statement of changes in equity
|
Note
|
Share
capital
£
|
Share
premium
£
|
Share based payments
reserve
£
|
Other
reserves
£
|
Retained
losses
£
|
Total
£
|
Non Controlling
Interest
£
|
Total
|
Balance as at 1 April 2022
|
|
3,109,804
|
39,077,403
|
17,240
|
325,583
|
(8,400,850)
|
34,129,180
|
(52,667)
|
34,076,513
|
Profit/(Loss) for the
year
|
|
-
|
-
|
-
|
-
|
(18,563,996)
|
(18,563,996)
|
1,650
|
(18,562,346)
|
Other comprehensive loss for the year
|
|
|
|
|
|
|
|
|
|
Items that may be subsequently reclassified to profit or
loss
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Total comprehensive loss for the year
|
|
-
|
-
|
-
|
-
|
(18,563,996)
|
(18,563,996)
|
(1,650)
|
(18,562,346)
|
Share based payments
|
|
-
|
-
|
1,605
|
-
|
-
|
1,605
|
-
|
1,605
|
Equity component of CLN issued in
period
|
|
-
|
-
|
-
|
51,798
|
-
|
51,798
|
-
|
51,798
|
Total transactions with owners, recognised directly in
equity
|
|
-
|
-
|
1,605
|
51,798
|
-
|
53,403
|
-
|
53,403
|
Balance as at 31 March 2023
|
|
3,109,804
|
39,077,403
|
18,845
|
377,381
|
(26,964,846)
|
15,618,587
|
(51,017)
|
15,567,570
|
|
|
|
|
|
|
|
|
|
| |
Balance as at 1 April 2023
|
|
3,109,804
|
39,077,403
|
18,845
|
377,381
|
(26,964,846)
|
15,618,587
|
(51,017)
|
15,567,570
|
Profit/(Loss) for the
year
|
|
-
|
-
|
-
|
-
|
(15,932,380)
|
(15,932,380)
|
22,277
|
(15,910,103)
|
Other comprehensive loss for the year
|
|
|
|
|
|
|
|
|
|
Items that may be subsequently reclassified to profit or
loss
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Total comprehensive loss for the year
|
|
-
|
-
|
-
|
-
|
(15,932,380)
|
(15,932,380)
|
22,277
|
(15,910,103)
|
Expired options
|
|
-
|
-
|
(16,360)
|
-
|
16,360
|
-
|
-
|
-
|
Equity component of CLN issued in
period
|
|
-
|
-
|
-
|
138,634
|
-
|
138,634
|
-
|
138,634
|
Issue of shares
|
|
39,254
|
1,733,322
|
-
|
-
|
-
|
1,772,576
|
-
|
1,772,576
|
Total transactions with owners, recognised directly in
equity
|
|
39,254
|
1,733,322
|
(16,360)
|
138,634
|
16,360
|
1,911,210
|
-
|
1,911,210
|
Balance as at 31 March 2024
|
|
3,149,058
|
40,810,725
|
2,485
|
516,015
|
(42,880,866)
|
1,597,417
|
(28,740)
|
1,568,677
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
Note
|
Share
capital
£
|
Share
premium
£
|
Share based payments
reserve
£
|
Other
reserves
£
|
Retained
losses
£
|
Total
equity
£
|
Balance as at 1 April 2022
|
|
3,109,804
|
39,077,403
|
17,240
|
325,583
|
(3,508,817)
|
39,021,213
|
Loss for the year
|
|
-
|
-
|
-
|
-
|
(21,180,437)
|
(21,180,437)
|
Total comprehensive loss for the period
|
|
-
|
-
|
-
|
-
|
(21,180,437)
|
(21,180,437)
|
Share based payments
|
|
-
|
-
|
1,605
|
-
|
-
|
1,605
|
Equity component of CLN issued in
the period
|
|
-
|
-
|
-
|
51,798
|
-
|
51,798
|
Total transactions with owners, recognised directly in
equity
|
|
-
|
-
|
1,605
|
51,798
|
-
|
53,403
|
Balance as at 31 March 2023
|
|
3,109,804
|
39,077,403
|
18,845
|
377,381
|
(24,689,254)
|
17,894,179
|
|
|
|
|
|
|
|
|
Balance as at 1 April
2023
|
|
3,109,804
|
39,077,403
|
18,845
|
377,381
|
(24,689,254)
|
17,894,179
|
Loss for the year
|
|
-
|
-
|
-
|
-
|
(17,185,547)
|
(17,185,547)
|
Total comprehensive loss for the year
|
|
-
|
-
|
-
|
-
|
(17,185,547)
|
(17,185,547)
|
Expired options
|
|
-
|
-
|
(16,360)
|
-
|
16,360
|
-
|
Equity component of CLN issued in
the period
|
|
-
|
-
|
-
|
138,634
|
-
|
138,634
|
Issue of shares
|
|
39,254
|
1,733,322
|
-
|
-
|
-
|
1,772,576
|
Total transactions with owners, recognised directly in
equity
|
|
39,254
|
1,733,322
|
(16,360)
|
138,634
|
16,360
|
1,911,210
|
Balance as at 31 March 2024
|
|
3,149,058
|
40,810,725
|
2,485
|
516,015
|
(41,858,441)
|
2,619,842
|
|
|
|
|
|
|
|
| |
Consolidated statements of cash flows
|
Note
|
|
31 March
2024
£
|
31 March
2023
£
|
|
Cash flows from operating activities
|
|
|
|
|
|
(Loss)/profit before income
tax
|
|
|
(15,910,103)
|
(18,562,346)
|
|
Adjustments for:
|
|
|
|
|
|
Depreciation and
amortisation
|
|
|
1,578,916
|
2,839,889
|
|
Disposal of PPE
|
|
|
(650)
|
-
|
|
Share based payments
|
23
|
|
-
|
1,605
|
|
Impairments
|
|
|
15,317,338
|
16,558,296
|
|
Net finance
(income)/costs
|
|
|
130,546
|
81,518
|
|
Gain on disposal of
subsidiaries
|
|
|
(164,300)
|
|
|
Provision for deferred tax
liabilities
|
|
|
(1,485,096)
|
(1,573,992)
|
|
Changes in working
capital:
|
|
|
|
|
|
(Increase)/Decrease in trade and
other receivables
|
|
|
394,606
|
(433,296)
|
|
Increase/(Decrease) in trade and
other payables
|
|
|
(160,651)
|
121,131
|
|
Net cash used in operating activities
|
|
|
(299,394)
|
(967,195)
|
|
Cash flows from investing activities
|
|
|
|
|
|
Sale/(Purchase) of property, plant
and equipment
|
12
|
|
837
|
(8,788)
|
|
Purchase of intangible
assets
|
14
|
|
(1,020,516)
|
(1,456,436)
|
|
Net cash from disposal of
subsidiaries
|
|
|
187,204
|
-
|
|
Net cash used in investing activities
|
|
|
(832,475)
|
(1,465,224)
|
|
Cash flows from financing activities
|
|
|
|
|
|
Proceeds from issue of share
capital
|
|
|
900,000
|
-
|
|
Proceeds from
Borrowings
|
|
|
-
|
2,250,000
|
|
Repayment of leasing
liabilities
|
|
|
(10,868)
|
(10,387)
|
|
Net cash generated from financing
activities
|
|
|
889,132
|
2,239,613
|
|
Net decrease/(increase) in cash and cash
equivalents
|
|
|
(242,737)
|
(192,806)
|
|
Cash and cash equivalents at beginning of
year
|
|
|
280,584
|
473,390
|
|
Cash and cash equivalents at end of year
|
17
|
|
37,847
|
280,584
|
|
|
|
|
| |
Notes to the financial statements
1. General
information
Insig AI plc is a public company
limited by shares, domiciled and incorporated in England and Wales
and its activities are as described in the Strategic
Report.
These financial statements are
prepared in pounds sterling being the currency of the primary
economic environment in which the Group operates.
2. Summary of
significant accounting policies
The principal Accounting Policies
applied in the preparation of these Consolidated Financial
Statements are set out below. These Policies have been consistently
applied to all the periods presented, unless otherwise
stated.
2.1. Basis of preparation of Financial Statements
The
Group and Company Financial Statements have been prepared in
accordance with UK-adopted international accounting standards in
conformity with the requirements of the Companies Act 2006. The
Group and Company Financial Statements have also been prepared
under the historical cost convention.
The
Financial Statements are presented in Pound Sterling rounded to the
nearest pound.
The
preparation of Financial Statements in conformity with UK adopted
International Accounting Standards (IAS) requires the use of
certain critical accounting estimates. It also requires management
to exercise its judgement in the process of applying the Accounting
Policies. The areas involving a higher degree of judgement or
complexity, or areas where assumptions and estimates are
significant to the Group and Company Financial Statements are
disclosed in Note 4.
2.2. New and amended
standards
The following amendments to
standards have become effective for the first time for annual
reporting periods commencing on 1 January 2023 and have been
adopted in preparing these financial statements:
Standard
|
|
Impact on initial application
|
|
Effective date
|
IAS 1 (Amendments) and IFRS
Practice Statement 2
|
|
Disclosure of Accounting
Policies
|
|
1 January 2023
|
IAS 8 (Amendments)
|
|
Definition of Accounting
Estimate
|
|
1 January 2023
|
IAS 12 Income Taxes
(Amendments)
|
|
Deferred Tax Related to Assets and
Liabilities Arising from a Single Transaction
|
|
1 January 2023
|
The adoption of these amendments
had no material impact on the financial statements.
At the date of approval of these
financial statements, the following amendments to IFRS which have
not been applied in these financial statements were in issue, but
not yet effective, until annual periods beginning on 1 January
2024:
Standard
|
|
Impact on initial application
|
|
Effective date
|
IAS 7 (Amendments) and IFRS
7
|
|
Supplier Finance
Arrangements
|
|
1 January 2024
|
IAS 1 (Amendments)
|
|
Classification of Liabilities as
Current or Non-Current
|
|
1 January 2024
|
IFRS 16 (Amendments)
|
|
Lease Liability in a Sale and
Leaseback
|
|
1 January 2024
|
IAS 1 (Amendments)
|
|
Presentation of Financial
Statements
|
|
1 January 2024
|
IAS 1 (Amendments)
|
|
Non-Current Liabilities with
Covenants
|
|
1 January 2024
|
IAS 21 (Amendments)
|
|
Lack of Exchangeability
|
|
1 January 2024
|
*Subject to endorsement by the
UK
2.3. Basis of
Consolidation
The Consolidated Financial
Statements consolidate the financial statements of the Company and
its subsidiaries made up to 31 March 2024. Subsidiaries are
entities over which the Group has control. Control is achieved when the Group is exposed, or has rights,
to variable returns from its involvement with the investee and has
the ability to affect those returns through its power over the
investee.
Generally, there is a presumption
that a majority of voting rights result in control. To support this
presumption and when the Group has less than a majority of the
voting or similar rights of an investee, the Group considers all
relevant facts and circumstances in assessing whether it has power
over an investee, including:
· The
contractual arrangement with the other vote holders of the
investee;
· Rights arising from other contractual arrangements;
and
· The
Group's voting rights and potential voting rights
The Group re-assesses whether or
not it controls an investee if facts and circumstances indicate
that there are changes to one or more of the three elements of
control. Subsidiaries are fully
consolidated from the date on which control is transferred to the
Group. They are deconsolidated from the date that control ceases.
Assets, liabilities, income and expenses of a subsidiary acquired
or disposed of during the period are included in the consolidated
financial statements from the date the Group gains control until
the date the Group ceases to control the subsidiary.
Investments in subsidiaries are
accounted for at cost less impairment within the parent company
financial statements. Where necessary, adjustments are made to the
financial statements of subsidiaries to bring the accounting
policies used in line with those used by other members of the
Group. All significant intercompany transactions and balances
between Group enterprises are eliminated on
consolidation.
2.4. Revenue
recognition
Revenue is measured at the fair
value of the consideration received or receivable, and represent
amounts receivable for goods supplied, stated net of discounts,
returns and value added taxes. Under IFRS 15 there is a five-step
approach to revenue recognition which is adopted across all revenue
streams. The process is:
· Step
1: Identify the contract(s) with a customer;
· Step
2: Identify the performance obligations in the
contract;
· Step
3: Determine the transaction price;
· Step
4: Allocate the transaction price to the performance obligations in
the contract; and
· Step
5: Fees are recognised once the work is completed and provided to
the client.
The Group has two types of revenue
streams being machine learning and data services and sports
activities.
Machine learning and Data services
revenue comprises of:
1. ESG Research
Tool
Fees are recognised as the agreed
work is conducted.
2. Machine Readable
Data
Fees are recognised as the agreed
work is conducted.
3. Bespoke Data
Science Solutions
Charged on a project basis and
includes work related to data migration, design fees, communication
fees and technological services. The fees are recognised as the
agreed work in conducted.
For the services detailed above,
revenue is recognised and invoiced in accordance with milestones
agreed within each contract with the customer, which can vary on a
case-by-case basis. In all scenarios, the revenue is recognised in
accordance with the provision of the agreed services provided or,
where the quantum and timing of the services can be difficult to
predict, rateable over the period of the agreement. Depending on
the client, invoices can be monthly, quarterly or ad-hoc. Invoices
can be adjusted in situations where the agreed scope of work is
exceeded or additional work is applied.
Up until the sale of Sport in
Schools, sports activities revenue was recognised once performance
obligations have been satisfied and work is completed with payment
due in advance of the performance obligations. Under the Group's
standard contract terms, customers may be offered refunds for
cancellation of sports and leisure activities. It is considered
highly probable that a significant reversal in the revenue
recognised will not occur given the consistent low level of refunds
in prior years.
2.5. Going
concern
The preparation of financial
statements requires an assessment on the validity of the going
concern assumption. The Directors have reviewed projections for a
period of at least 12 months from the date of approval of the
financial statements as well as potential opportunities. Any
potential short falls in funding have been identified and the steps
to which Directors are able to mitigate such scenarios and/or defer
or curtail discretionary expenditures should these be required have
been considered. The directors have noted in their going concern
assessment that the convertible loan notes provided to the Company
are due for repayment on 30 September 2025 and the Company has
forecast the receipt of a research and development refund in the
coming months.
In approving the financial
statements, the Board have recognised that there is a material
uncertainty. This conclusion was reached after an in-depth review
of the current sales position of the Group, as well as the
uncertainty surrounding the forecasted sales pipeline of the Group.
Therefore, operational results continue at a loss as the Group is
not cash generative. The financial statements do not include any
adjustments that may arise in the event of the Group not being a
going concern. However, having made enquiries and considered the
uncertainties outlined above, the Directors have a reasonable
expectation that the Group will continue to be able to raise
finance as required over this period to enable it to continue in
operation and existence for the foreseeable future.
Accordingly, the Board believes it is appropriate to adopt the
going concern basis in the preparation of the financial
statements.
2.6. Foreign
currencies
(a) Functional and presentation currency
Items included in the Financial
Statements of each of the Group's entities are measured using the
currency of the primary economic environment in which the entity
operates (the 'functional currency'). The functional currency of
the UK parent entity and UK subsidiaries is Pounds Sterling, The
Financial Statements are presented in Pounds Sterling which the
Company's functional and Group's presentational
currency.
(b) Transactions and balances
Foreign currency transactions are
translated into the functional currency using the exchange rates
prevailing at the dates of the transactions or valuation where such
items are re-measured. Foreign exchange gains and losses resulting
from the settlement of such transactions and from the translation
at period-end exchange rates of monetary assets and liabilities
denominated in foreign currencies are recognised in the income
statement.
2.7. Intangible
assets
Goodwill arising on consolidation
represents the excess of the cost of acquisition over the Group's
interest in the fair value of the identifiable assets and
liabilities of subsidiary entities at the date of acquisition.
Goodwill is initially recognised as an asset at cost and is
subsequently measured at cost less any accumulated impairment
losses. Goodwill which is recognised as an asset is reviewed for
impairment at least annually. Any impairment is recognised
immediately in the statement of comprehensive income and is not
subsequently reversed.
For the purpose of impairment
testing, goodwill is allocated to each of the Group's cash
generating units expected to benefit from synergies of the
combination. Cash-generating units to which goodwill has been
allocated are tested for impairment annually, or more frequently
when there is an indication that the unit may be impaired. If the
recoverable amount of the cash generating unit is less than the
carrying amount of the unit, the impairment loss is allocated first
to reduce the carrying amount of any goodwill allocated to the unit
then to the other assets of the unit pro-rata on the basis of the
carrying amount of each asset in the unit. An impairment loss
recognised for goodwill is not reversed in a subsequent
period.
On disposal of a subsidiary,
associate or jointly controlled entity, the amount of goodwill is
included in the determination of the profit or loss on
disposal.
Goodwill arising on acquisitions
before the date of transition to IFRS's has been retained at the
previous UK GAAP amounts subject to being tested for impairment at
that date.
Development costs are expensed in
arriving at the operating profit or loss for the year unless the
Directors are satisfied as to the technical, commercial and
financial viability of individual project. In this situation, the
expenditure is recognised as an asset and is reviewed for
impairment on an annual basis. Amortisation is provided on all
development costs to write off the cost less estimated residual
value of each asset over its expected useful economic life on a
straight line basis at the following annual rates:
Technology assets - 7 years
straight line
Development costs - 7 years
straight line
Customer relationships - 13 years
straight line
Databases - 7 years straight
line
2.8. Investments in
subsidiaries
Investments in Group undertakings
are stated at cost, which is the fair value of the consideration
paid, less any impairment provision.
2.9. Property, plant and
equipment
Property, Plant and equipment is
stated at cost less accumulated depreciation and any accumulated
impairment losses. Depreciation is provided on all property, plant
and equipment to write off the cost less estimated residual value
of each asset over its expected useful economic life on a straight
line basis at the following annual rates:
Plant and Equipment - 25% and 10%
straight line
Subsequent costs are included in
the asset's carrying amount or recognised as a separate asset, as
appropriate, only when it is probable that future economic benefits
associated with the item will flow to the Group and the cost of the
item can be measured reliably. The carrying amount of the replaced
part is derecognised. All other repairs and maintenance are charged
to the income statement during the financial period in which they
are incurred.
The assets' residual values and
useful lives are reviewed, and adjusted if appropriate, at the end
of each reporting period.
An asset's carrying amount is
written down immediately to its recoverable amount if the asset's
carrying amount is greater than its estimated recoverable amount.
If an impairment review is conducted following an indicator of
impairment, assets which are not able to be assessed for impairment
individually are assessed in combination with other assets within a
cash generating unit.
Gains and losses on disposal are
determined by comparing the proceeds with the carrying amount and
are recognised within 'Other (losses)/gains' in the Income
Statement.
2.10.
Impairment of
non-financial assets
Assets that have an indefinite
useful life, for example, intangible assets not ready to use, and
goodwill, are not subject to amortisation and are tested annually
for impairment. Property, plant and equipment is reviewed for
impairment whenever events or changes in circumstances indicate
that the carrying amount may not be recoverable. An impairment loss
is recognised for the amount by which the asset's carrying amount
exceeds its recoverable amount. The recoverable amount is the
higher of an asset's fair value less costs to sell and value in
use. For the purposes of assessing impairment, assets are grouped
at the lowest levels for which there are separately identifiable
cash flows (cash generating units). Non-financial assets that
suffered impairment are reviewed for possible reversal of the
impairment at each reporting date.
2.11.
Financial
Instruments
Financial assets and financial
liabilities are recognised in the Group's statement of financial
position when the Group becomes a party to the contractual
provisions of the instrument. Financial assets and financial
liabilities are only offset and the net amount reported in the
consolidated statement of financial position and income statement
when there is a currently enforceable legal right to offset the
recognized amounts and the Group intends to settle on a net basis
or realise the asset and liability simultaneously.
Financial assets and financial
liabilities are initially measured at fair value. Transaction costs
that are directly attributable to the acquisition or issue of
financial assets and financial liabilities (other than financial
assets and financial liabilities at fair value through profit or
loss) are added to or deducted from the fair value of the financial
assets or financial liabilities, as appropriate, on initial
recognition. Transaction costs directly attributable to the
acquisition of financial assets or financial liabilities at fair
value through profit or loss are recognised immediately in profit
or loss.
Debt instruments are classified as
financial assets measured at fair value through other comprehensive
income where the financial assets are held within the company's
business model whose objective is achieved by both collecting
contractual cash flows and selling financial assets, and the
contractual terms of the financial asset give rise on specified
dates to cash flows that are solely payments of principal and
interest on the principal amount outstanding.
Financial assets
All Group's recognised financial
assets are measured subsequently in their entirety at either
amortised cost or fair value, depending on the classification of
the financial assets.
Classification of financial
assets
Financial assets that meet the
following conditions are measured subsequently at amortised cost
using the effective interest rate method:
• the financial asset is
held within a business model whose objective is to hold financial
assets in order to collect contractual cash flows; and
• the contractual terms of the financial asset give rise on specified dates to cash flows that are solelypayments
of principal and interest on the principal amount outstanding.
The Company classifies the
following financial assets at fair value through profit or loss
(FVPL):
• debt instruments that do
not qualify for measurement at either amortised cost (see above) or
FVOCI;
• equity investments that
are held for trading; and
• equity investments for
which the entity has not elected to recognised fair value gains and
losses through OCI.
The Group does not hold any
financial assets that meet conditions for subsequent recognition at
fair value through other comprehensive income ("FVTOCI").
Impairment of financial
assets
The Group recognises a financial
asset only when the contractual rights to the cash flows from the
asset expire, or when it transfers the financial asset and
substantially all the risks and rewards of ownership of the asset
to another entity. If the Group neither transfers nor
retains substantially all the risks and
rewards of ownership and continues to control the transferred
asset, the Group recognises its retained interest in the asset and
an associated liability for amounts it may have to pay. If the
Group retains substantially all the risks and rewards of ownership
of a transferred financial asset, the Group continues to recognise
the financial asset and also recognises a collateralised
borrowing for the proceeds received.
Financial liabilities
The classification of financial
liabilities at initial recognition depends on the purpose for which
the financial liability was issued and its characteristics. All
purchases of financial liabilities are recorded on trade date,
being the date on which the Group becomes party to the contractual
requirements of the financial liability. Unless otherwise indicated
the carrying amounts of the Group's financial liabilities
approximate to their fair values.
The Group's financial liabilities
consist of financial liabilities measured at amortised cost and
financial liabilities at fair value through profit or
loss.
Financial liabilities measured
subsequently at amortised cost
Financial liabilities that are not
(i) contingent consideration of an acquirer in a business
combination, (ii) held for trading, or (iii) designated as at
FVTPL, are measured subsequently at amortised cost using the
effective interest method. The Group's financial liabilities
measured at amortised cost comprise convertible loan notes, trade
and other payables, and accruals.
The effective interest method is a
method of calculating the amortised cost of a financial
asset/liability and of allocating interest income/expense over the
relevant period. The effective interest rate is the rate that
discounts estimated future cash receipts/payments through the
expected life of the financial asset/liability or, where
appropriate, a shorter period.
Convertible loan
notes
On issue of a convertible loan,
the fair value of the liability component is determined by
discounting the contractual future cash flows using a market rate
for a non-convertible instrument with similar terms. This value is
carried as a liability on the amortised cost basis unless is
designated as a Fair Value Through Profit and Loss ("FVTPL") at
inception.
Financial instruments designated
as FVTPL are classified in this category irrevocably at inception
and are derecognised when extinguished. They are initially measured
at fair value and transaction costs directly attributable to their
acquisition are recognised immediately in profit or loss.
Subsequent changes in fair values are recognised in the income
statement with profit or loss.
Equity instruments are
instruments that evidence a residual interest in the assets of an
entity after deducting all of its liabilities. Therefore, when the
initial carrying amount of a compound financial instrument is
allocated to its equity and liability components, the equity
component is assigned the residual amount after deducting from the
fair value of the instrument as a whole the amount separately
determined for the liability component. The value of any derivative
features (such as a call option) embedded in the compound financial
instrument other than the equity component (such as an equity
conversion option) is included in the liability
component.
Derecognition of financial
liabilities
A financial liability (in whole or
in part) is recognised when the Group has extinguished its
contractual obligations, it expires or is cancelled. Any gain or
loss on derecognition is taken to the income statement.
2.12.
Leases
The Group leases certain property,
plant and equipment.
The lease liability is initially
measured at the present value of the lease payments that are not
paid. Lease payments generally include fixed payments less any
lease incentives receivable. The lease liability is discounted
using the interest rate implicit in the lease or, if that rate
cannot be readily determined, the Group's incremental borrowing
rate. The Group estimates the incremental borrowing rate based on
the lease term, collateral assumptions, and the economic
environment in which the lease is denominated. The lease liability
is subsequently measured at amortized cost using the effective
interest method. The lease liability is remeasured when the
expected lease payments change as a result of new assessments of
contractual options and residual value guarantees.
The right-of-use asset is
recognised at the present value of the liability at the
commencement date of the lease less any incentives received from
the lessor. Added to the right-of-use asset are initial direct
costs, payments made before the commencement date, and estimated
restoration costs. The right-of-use asset is subsequently
depreciated on a straight-line basis from the commencement date to
the earlier of the end of the useful life of the right-of-use asset
or the end of the lease term. The right-of-use asset is
periodically reduced by impairment losses, if any, and adjusted for
certain remeasurements of the lease liability.
Each lease payment is allocated
between the liability and finance charges. The corresponding rental
obligations, net of finance charges, are included in lease
liabilities, split between current and non-current depending on
when the liabilities are due. The interest element of the finance
cost is charged to the Statement of Profit and Loss over the lease
period so as to produce a constant periodic rate of interest on the
remaining balance of the liability for each period. Assets obtained
under finance leases are depreciated over their useful lives. The
lease liabilities are shown in Note
19.
Exemptions are applied for short
life leases and low value assets, with payment made under operating
leases charged to the Consolidated Statement of Comprehensive
Income on a straight-line basis of the period of the
lease.
2.13.
Cash and cash
equivalents
Cash and cash equivalents comprise
cash at bank and in hand.
2.14.
Equity
Equity comprises the
following:
· "Share capital" represents the nominal value of the Ordinary
shares;
· "Share Premium" represents consideration less nominal value
of issued shares and costs directly attributable to the issue of
new shares;
· "Treasury shares" are the portion of shares that a company
keeps in its own treasury. These can be gifted or
purchased.
· "Other reserves" represents the merger reserve, revaluation
reserve and share option reserve where;
o "Merger reserve" represents the difference between the fair
value of an acquisition and the nominal value of the shares
allotted in a share exchange;
o "Share option reserve" represents share options awarded by
the group;
· "Retained earnings" represents retained losses.
2.15.
Share capital
and share premium
Ordinary shares are classified as
equity. Incremental costs directly attributable to the issue of new
shares or options are shown in equity, as a deduction, net of tax,
from the proceeds provided there is sufficient premium
available.
2.16.
Share based
payments
The Group operates a number of
equity-settled, share-based schemes, under which the Group receives
services from employees or third party suppliers as consideration
for equity instruments (options and warrants) of the Group. The
fair value of the third party suppliers' services received in
exchange for the grant of the options is recognised as an expense
in the Income Statement or charged to equity depending on the
nature of the service provided. The value of the employee services
received is expensed in the Income Statement and its value is
determined by reference to the fair value of the options
granted:
· including any market performance conditions;
· excluding the impact of any service and non-market
performance vesting conditions (for example, profitability or sales
growth targets, or remaining an employee of the entity over a
specified time period); and
· including the impact of any non-vesting conditions (for
example, the requirement for employees to save).
The fair value of the share
options and warrants are determined using the Black Scholes
valuation model.
Non-market vesting conditions are
included in assumptions about the number of options that are
expected to vest. The total expense or charge is recognised over
the vesting period, which is the period over which all of the
specified vesting conditions are to be satisfied. At the end of
each reporting period, the entity revises its estimates of the
number of options that are expected to vest based on the non-market
vesting conditions. It recognises the impact of the revision to
original estimates, if any, in the Income Statement or equity as
appropriate, with a corresponding adjustment to a separate reserve
in equity.
When the options are exercised,
the Group issues new shares. The proceeds received, net of any
directly attributable transaction costs, are credited to share
capital (nominal value) and share premium when the options are
exercised.
2.17.
Taxation
Corporation tax is the main tax
that a limited company must pay based on their profits, in addition
to any gains from the sale of assets. For the year ended 31 March
2024, corporation tax is calculated as 25% of a company's profit
for the year. No current tax is yet payable in view of the losses
to date.
Deferred tax is recognised for
using the liability method in respect of temporary differences
arising from differences between the carrying amount of assets and
liabilities in the consolidated financial statements and the
corresponding tax bases used in the computation of taxable profit.
However, deferred tax liabilities are not recognised if they arise
from the initial recognition of goodwill; deferred tax is not
accounted for if it arises from initial recognition of an asset or
liability in a transaction other than a business combination that
at the time of the transaction affects neither accounting nor
taxable profit or loss.
In principle, deferred tax
liabilities are recognised for all taxable temporary differences
and deferred tax assets (including those arising from investments
in subsidiaries), are recognised to the extent that it is probable
that taxable profits will be available against which deductible
temporary differences can be utilised.
Deferred income tax assets are
recognised on deductible temporary differences arising from
investments in subsidiaries only to the extent that it is probable
the temporary difference will reverse in the future and there is
sufficient taxable profit available against which the temporary
difference can be used.
Deferred tax liabilities are
recognised for taxable temporary differences arising on investments
in except where the Group is able to control the reversal of the
temporary difference and it is probable that the temporary
difference will not reverse in the foreseeable future.
Deferred tax assets and
liabilities are offset when there is a legally enforceable right to
offset current tax assets against current tax liabilities and when
the deferred tax assets and liabilities relate to income taxes
levied by the same taxation authority on either the same taxable
entity or different taxable entities where there is an intention to
settle the balances on a net basis.
Deferred tax is calculated at the
tax rates (and laws) that have been enacted or substantively
enacted by the statement of financial position date and are
expected to apply to the period when the deferred tax asset is
realised or the deferred tax liability is settled.
Deferred tax assets and
liabilities are not discounted.
2.18.
Discontinued
operations
Discontinued operations define the
parts of a Group Company that are sold, shut down, or no longer
operational during the financial year of the Group. The financial
performance of discontinued operations is presented separately to
the Group in the consolidated statement of income, and the
statement of cash flows.
2.19.
Research and
development
Expenditure on research activities
undertaken with the prospect of gaining new scientific or technical
knowledge and understanding is recognised in the income statement
as an expense as incurred. Development costs that are directly
attributable to the design and testing of identifiable and unique
products controlled by the Group are recognised as intangible
assets where the following criteria are met:
- It is technically feasible to complete the asset so that it
will be available for use;
- Management intends to complete the asset and use or sell
it;
- There is an ability to use or sell the asset;
- It can be demonstrated how the asset will generate probable
future economic benefits;
- Adequate technical, financial and other resources to complete
the development and to use or sell the asset are available;
and
- The expenditure attributable to the asset during its
development can be reliably measured.
Directly attributable costs that
are capitalised as part of the asset include the product
development employee costs and an appropriate portion of relevant
overheads. Other development expenditures that do not meet these
criteria are recognised as an expense as incurred. Development
costs previously recognised as an expense are not recognised as an
asset in a subsequent period.
3. Financial risk management
3.1. Financial risk
factors
The Group's activities expose it
to a variety of financial risks: market risk, credit risk and
liquidity risk. The Group's overall risk management programme
focuses on the unpredictability of financial markets and seeks to
minimise potential adverse effects on the Group's financial
performance. None of these risks are hedged.
Risk management is carried out by
the management team under policies approved by the Board of
Directors.
Market
risk
The Group is exposed to market
risk, primarily relating to interest rate and foreign exchange. The
Group has not sensitised the figures for fluctuations in interest
rates and foreign exchange as the Directors are of the opinion that
these fluctuations would not have a significant impact on the
Financial Statements at the present time. The Directors will
continue to assess the effect of movements in market risks on the
Group's financial operations and initiate suitable risk management
measures where necessary.
Credit
risk
Credit risk arises from cash and
cash equivalents as well as loans to subsidiaries and outstanding
receivables. Management does not expect any losses from
non-performance of these receivables. The amount of exposure to any
individual counter party is subject to a limit, which is assessed
by the Board.
The Group considers the credit
ratings of banks in which it holds funds in order to reduce
exposure to credit risk.
Impairment provisions for loans to
subsidiaries are recognised based on a forward-looking expected
credit loss model. The methodology used to determine the amount of
the provision is based on whether there has been a significant
increase in credit risk since initial recognition of the financial
asset. At year end it was assessed credit risk was low due to
future profits forecast therefore no provision was
required.
For those where the credit risk
has not increased significantly since initial recognition of the
financial asset, twelve month expected credit losses along with
gross interest income are recognised. For those for which credit
risk has increased significantly, lifetime expected credit losses
along with the gross interest income are recognised. For those that
are determined to be credit impaired, lifetime expected credit
losses along with interest income on a net basis are recognised. At
year end all receivables were less than 60 day outstanding and
deemed highly likely to be received therefore no provision was
required.
Liquidity
risk
In keeping with similar sized
groups, the Group's continued future operations depend on the
ability to raise sufficient working capital through the issue of
equity share capital or debt. The Directors are reasonably
confident that adequate funding will be forthcoming with which to
finance operations. Controls over expenditure are carefully
managed. With exception to deferred taxation, financial liabilities
are all due within one year.
3.2. Capital risk
management
The Group's objectives when
managing capital are to safeguard the Group's ability to continue
as a going concern, to enable the Group to continue its activities,
and to maintain an optimal capital structure to reduce the cost of
capital. In order to maintain or adjust the capital structure, the
Group may adjust the issue of shares or sell assets to reduce
debts.
The Group defines capital based on
the total equity of the Company. The Group monitors its level of
cash resources available against future activities and may issue
new shares in order to raise further funds from time to
time.
4. Critical accounting
estimates and judgements
The preparation of the Financial
Statements in conformity with the requirements of the Companies Act
2006 obliges management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the
financial statements and the reported amount of expenses during the
period.
Estimates and judgements are
regularly evaluated and are based on historical experience and
other factors, including expectations of future events that are
believed to be reasonable under the circumstances.
Items subject to such estimates
and assumptions, that have a significant risk of causing a material
adjustment to the carrying amounts of assets and liabilities within
the next financial years, include but are not limited
to:
Impairment of goodwill
Determining whether goodwill is
impaired requires an estimation of the value in use of the cash
generating units to which the goodwill has been allocated. The
value in use calculation requires the entity to estimate the future
cash flows expected to arise from the cash generating unit and a
suitable discount rate in order to calculate present value. The
carrying amount of goodwill is the deemed cost on first time
application of UK Adopted International Accounting Standards in
conformity with the requirements of the Companies Act
2006.
Details of the carrying value of
goodwill at the period end and the impairment review assessment are
given in Note 14.
Impairment of intangible assets
The Company follows the guidance
of IAS 36 to determine when impairment indicators exist for its
intangible assets. When impairment indicators exist, the Company is
required to make a formal estimate of the recoverable amount of its
intangible assets. This determination requires significant
judgement. In making this judgement, management evaluates external
and internal factors, such as significant adverse changes in the
technological market, economic or legal environment in which the
Company operates as well as the results of its ongoing development
programs. Management also considers the carrying amount of the
Company's net assets in relation to its market capitalisation as a
key indicator. For the year ended 31 March 2024, future sales
forecasts related to the intangible assets of the Company were
taken into consideration when finalising the impairment
value. Further details of the impairment of intangible assets
are included in note 14.
Capitalised development costs
Development costs incurred in
building the Group's key platform for future expansion have been
capitalised in accordance with the requirements of IAS38. The
majority of these costs consist of salary expenses to which an
estimated proportion of development time has been applied. Salary
expenses are capitalised because the work done is expected to lead
to future economic benefits for the Group. The proportion of salary
expenses that are capitalised is based on the judgement of
management, taking IAS38 into account after reviewing how much each
employee contributes to the Company's development projects
respectively.
Investment in Subsidiaries
The Company considers the
recoverability of the investment in subsidiaries to be a key area
of judgment, and this is held at its carrying amount which is
expected to be recovered from the subsidiary. The directors believe
that the investment in subsidiaries balance at year end is
recoverable based on the directors' expectation around the
potential that the subsidiaries have to generate sufficient
economic benefits in the foreseeable future.
The investment in subsidiaries
includes loans as detailed in note 15. The loans are considered
recoverable by management, and the investments made have been
impaired in line with their level of recoverability.
Subsidiary investments are also
reviewed to decide on whether impairments will be required, based
on the valuation of the subsidiary's assets. Such impairments that
occurred during the year are detailed in note 15.
Going Concern
As discussed more fully in the in
the Strategic Report, these financial statements have been prepared
on the going concern basis. This approach is based on management's
judgement that cashflow requirements for the continued development
can be achieved through operating activities and additional
fundraising if required.
5. Segment
information
Business segments are identified
according to the different trading activities in the
Group.
During the year, the Group's
trading segments were machine learning and data services
representing revenue of £369,860 (2023: £693,734) and its sports
and leisure activities, comprising sports tuition at schools
representing its revenue of £928,807 (31 March 2023: £1,398,427 ).
All revenue was generated in the UK. The sport and leisure
activities were discontinued during the year as a result of the
subsidiaries that provided this service being disposed in November
2023. Consequentially, the revenue recognised from the sport and
leisure activities is representative of the period April to
November 2023.
31 March 2024
|
|
Machine learning and Data services
£
|
Sport in Schools
£
|
Total
£
|
Revenue
|
|
369,860
|
928,807
|
1,298,667
|
Cost of sales
|
|
-
|
(498,890)
|
(498,890)
|
Administrative expenses
|
|
(2,562,208)
|
(374,496)
|
(2,936,704)
|
Other gains/(losses)
|
|
(102,965)
|
164,093
|
61,128
|
Other income
|
|
3,160
|
384
|
3,544
|
Finance income
|
|
263
|
822
|
1,085
|
Finance costs
|
|
(126,390)
|
(4,156)
|
(130,546)
|
Impairments
|
|
(15,317,338)
|
-
|
(15,317,338)
|
Profit/(Loss) before tax per reportable
segment
|
|
(17,735,618)
|
216,564
|
(17,519,054)
|
Additions to intangible
assets
|
|
1,020,516
|
-
|
1,020,516
|
Reportable segment
assets
|
|
4,552,239
|
-
|
4,552,239
|
Reportable segment
liabilities
|
|
2,983,562
|
-
|
2,983,562
|
31 March 2023
|
|
Machine learning and Data services
£
|
Sport in Schools
£
|
Total
£
|
Revenue
|
|
693,734
|
1,398,427
|
2,092,161
|
Cost of sales
|
|
(51)
|
(732,915)
|
(732,966)
|
Administrative expenses
|
|
(5,484,356)
|
(640,413)
|
(6,124,769)
|
Other gains/(losses)
|
|
(15,796)
|
(7,572)
|
(23,368)
|
Other income
|
|
1,291,873
|
444
|
1,292,317
|
Finance income
|
|
101
|
-
|
101
|
Finance costs
|
|
(81,518)
|
-
|
(81,518)
|
Impairments
|
|
(16,558,296)
|
-
|
(16,558,296)
|
Profit/(Loss) before tax per reportable
segment
|
|
(20,154,309)
|
17,971
|
(20,136,338)
|
Additions to intangible
assets
|
|
1,456,436
|
-
|
1,456,436
|
Reportable segment
assets
|
|
20,809,036
|
566,580
|
21,375,616
|
Reportable segment
liabilities
|
|
5,544,528
|
263,518
|
5,808,046
|
|
|
|
|
|
6. Revenue
31 March 2024
|
|
Machine learning and Data services
£
|
Sport in Schools
£
|
Total
£
|
Revenue
|
|
369,860
|
928,807
|
1,298,667
|
31 March 2023
|
|
Machine learning and Data services
£
|
Sport in Schools
£
|
Total
£
|
Revenue
|
|
693,734
|
1,398,427
|
2,092,161
|
Lodbrok Capital LLP were the only
customer that accounted for over 10% of the Group's revenue for the
year, contributing £179,675 (2023: Lodbrok Capital LLP -
£334,657).
7. Administrative
expenses - continued operations
|
|
|
|
Year ended
31 March 2024 - continued operations
£
|
Year ended
31 March 2023 - Group
£
|
|
|
|
|
|
Employee salaries and
costs
|
82,150
|
1,374,989
|
|
Director remuneration
|
258,521
|
351,828
|
|
Office and expenses
|
24,821
|
152,481
|
|
Travel &
subsistence
|
18,738
|
47,587
|
|
Professional & consultancy
fees
|
335,791
|
635,774
|
|
IT & Software
|
-
|
81,902
|
|
Subscriptions
|
99,280
|
291,281
|
|
Insurance
|
82,144
|
106,719
|
|
Depreciation and
amortisation
|
1,554,998
|
2,839,889
|
|
Share option expense
|
-
|
1,605
|
|
Exchange related costs
|
94,191
|
67,452
|
|
Other expenses
|
11,574
|
173,262
|
|
Total administrative expenses
|
2,562,208
|
6,124,769
|
|
Of the above Group staff costs,
£711,605 (31 March 2023: £1,167,769 ) has been capitalised in
accordance with IAS 38 as development costs and are shown as an
intangible addition in the year.
Services provided by the Company's auditor and its
associates
During the year, the Group
(including overseas subsidiaries) obtained the following services
from the Company's auditors and its associates:
|
Group
|
|
Year ended 31 March 2024
£
|
Year ended 31 March 2023
£
|
Auditors' remuneration
|
80,300
|
70,500
|
8. Employee benefit
expense
|
Group
|
|
Company
|
Staff costs (excluding Directors)
|
Year ended
31 March 2024
£
|
Year ended
31 March 2023
£
|
|
Year ended
31 March 2024
£
|
Year ended
31 March 2023
£
|
Salaries and wages
|
183,887
|
2,081,959
|
|
-
|
-
|
Social security costs
|
46,043
|
305,479
|
|
-
|
-
|
Pension contributions
|
20,987
|
128,743
|
|
-
|
-
|
Other employment costs
|
1,973
|
13,668
|
|
-
|
-
|
|
252,890
|
2,529,849
|
|
-
|
-
|
The average monthly number of
employees for the Group during the year was 109 (31 March 2023:
112) and the average monthly number of employees for the Company
was nil (31 March 2023: nil).
Of the above Group staff costs,
£711,605 (31 March 2023: £1,167,769 ) has been capitalised in
accordance with IAS 38 as development costs and are shown as an
intangible addition in the year.
There were no employees in the
Company apart from Directors whose remuneration is disclosed in
Note 26.
9. Other
gains/(losses)
|
Group
|
|
Year ended
31 March 2024
£
|
Year ended
31 March 2023
£
|
Continued operations
|
|
|
Other Losses
|
(17,450)
|
23,368
|
Modification of convertible loan
notes
|
(96,374)
|
-
|
Other gains
|
10,859
|
-
|
Other gain/(losses)
|
(102,965)
|
23,368
|
Discontinued Operations
|
|
|
Profit on disposal of
subsidiary
|
164,300
|
-
|
Other Losses
|
(207)
|
-
|
Other gain/(losses)
|
61,128
|
23,368
|
10. Other operating
income
|
Group
|
|
Year ended
31 March 2024
£
|
Year ended
31 March 2023
£
|
Continued operations
|
|
|
Sale of equipment
|
3,160
|
444
|
|
3,160
|
444
|
Discontinued operations
|
|
|
Other income
|
386
|
-
|
|
3,546
|
-
|
11. Finance
income/(costs)
|
Group
|
|
Year ended
31 March 2024
£
|
Year ended
31 March 2023
£
|
Continued operations
|
|
|
Interest received from cash and
cash equivalents
|
263
|
101
|
Discontinued operations
|
|
|
Interest received from cash and
cash equivalents
|
822
|
-
|
Finance income
|
1,085
|
101
|
Continued operations
|
|
|
Loan interest
|
(126,390)
|
(81,518)
|
Discontinued operations
|
|
|
Loan interest
|
(4,156)
|
-
|
Finance Costs
|
(130,546)
|
(81,518)
|
12. Property, plant and
equipment
Group
|
|
|
Plant and equipment
£
|
Total
£
|
Cost
|
|
|
As at 1 April 2022
|
206,329
|
206,329
|
Additions
|
10,616
|
10,616
|
Acquired upon
acquisition
|
(54,332)
|
(54,332)
|
As at 31 March 2023
|
162,613
|
162,613
|
As at 1 April 2023
|
162,613
|
162,613
|
Additions
|
2,323
|
2,323
|
Disposals
|
(135,566)
|
(135,566)
|
As at 31 March 2024
|
29,370
|
29,370
|
Depreciation
|
|
|
As at 1 April 2022
|
140,665
|
140,665
|
Charge for the year
|
23,593
|
23,593
|
Acquired upon
acquisition
|
(39,293)
|
(39,293)
|
As at 31 March 2023
|
124,965
|
124,965
|
As at 1 April 2023
|
124,965
|
124,965
|
Charge for the year
|
23,980
|
23,980
|
Disposal
|
(125,227)
|
(125,227)
|
As at 31 March 2024
|
23,718
|
23,718
|
Net book value as at 31 March 2023
|
37,648
|
37,648
|
Net book value as at 31 March 2024
|
5,652
|
5,652
|
|
|
|
| |
All tangible assets shown above
are assets in use by the Group's subsidiary
undertakings.
13. Right of use Assets
Group
|
|
|
|
Right of Use leases
£
|
Total
£
|
Cost
|
|
|
As at 1 April 2022
|
154,180
|
154,180
|
Additions
|
-
|
-
|
Disposal
|
-
|
-
|
As at 31 March 2023
|
154,180
|
154,180
|
As at 1 April 2023
|
154,180
|
154,180
|
Additions
|
-
|
-
|
Disposal
|
(154,180)
|
(154,180)
|
As at 31 March 2024
|
-
|
-
|
Depreciation
|
|
|
As at 1 April 2022
|
115,635
|
115,635
|
Charge for the year
|
10,279
|
10,279
|
Disposal
|
-
|
-
|
As at 31 March 2023
|
125,914
|
125,914
|
As at 1 April 2023
|
125,914
|
125,914
|
Charge for the year
|
6,481
|
6,481
|
Disposal
|
(132,395)
|
(132,395)
|
As at 31 March 2024
|
-
|
-
|
Net book value as at 31 March 2023
|
28,266
|
28,266
|
Net book value as at 31 March 2024
|
-
|
-
|
|
|
|
|
| |
Right of Use Assets represent
leasehold premises from which the Group operates in relation to its
sports and leisure activities.
All right of use assets shown
above are assets in use by the Group's subsidiary
undertakings.
The right of use assets were
disposed of as part of the sale of Sport in Schools and Elms Group
that took place on 14 November 2023. As a result, they are no
longer recognised by the Group.
14. Intangible assets
Intangible assets comprise
goodwill and development costs.
|
|
|
|
|
|
|
Assets - Cost and Net Book Value
|
Goodwill
£
|
Development costs
£
|
Technology assets
£
|
Customer
relationships
£
|
Databases
£
|
Total
£
|
Cost
|
|
|
|
|
|
|
As at 1 April 2022
|
21,621,803
|
1,085,000
|
16,385,727
|
1,207,000
|
1,094,000
|
41,393,530
|
Additions
|
-
|
1,456,436
|
-
|
-
|
-
|
1,456,436
|
As at 1 April 2023
|
21,621,803
|
2,541,436
|
16,385,727
|
1,207,000
|
1,094,000
|
42,849,966
|
Additions
|
-
|
1,020,516
|
-
|
-
|
-
|
1,020,516
|
As at 31 March 2024
|
21,621,803
|
3,561,952
|
16,385,727
|
1,207,000
|
1,094,000
|
43,870,482
|
Amortisation
|
|
|
|
|
|
|
As at 1 April 2022
|
-
|
(1,085,000)
|
(1,964,556)
|
(74,724)
|
(52,095)
|
(3,176,375)
|
Amortisation
|
-
|
(537,328)
|
(2,018,000)
|
(94,404)
|
(156,285)
|
(2,806,017)
|
Impairment
|
(11,655,908)
|
(919,108)
|
(2,742,498)
|
(355,162)
|
(885,620)
|
(16,558,296)
|
As at 1 April 2023
|
(11,655,908)
|
(2,541,436)
|
(6,725,054)
|
(524,290)
|
(1,094,000)
|
(22,540,688)
|
Amortisation
|
-
|
(31,587)
|
(1,442,714)
|
(74,155)
|
-
|
(1,548,456)
|
Disposal/write-off
|
(60,000)
|
-
|
-
|
-
|
-
|
(60,000)
|
Impairment
|
(9,905,895)
|
-
|
(5,122,663)
|
(288,780)
|
-
|
(15,317,338)
|
As at 31 March 2024
|
(21,621,803)
|
(2,573,023)
|
(13,290,431)
|
(887,225)
|
(1,094,000)
|
(39,466,482)
|
Net book value 2023
|
9,965,895
|
-
|
9,660,673
|
682,710
|
-
|
20,309,278
|
Net book value 2024
|
-
|
988,929
|
3,095,296
|
319,775
|
-
|
4,404,000
|
|
|
|
|
|
|
| |
As part of the disposal of Sport
in Schools and Elms Group in November 2023, goodwill of £60,000 was
disposed of.
Development costs are
predominantly capitalised staff costs associated with enhancements
to the technology being developed by Insig Partners Limited. The
Group's technology, customer relationships and database technology
are acquired from the acquisitions undertaken during the
period.
Goodwill is recognised when a
business combination does not generate cash flows independently of
other assets or groups of assets. As a result, the recoverable
amount, being the value in use, is determined at a cash-generating
unit (CGU) level.
These CGUs represent the smallest
identifiable group of assets that generate cash flows. The CGUs are
deemed to be the assets within the operating units. Each CGU to
which goodwill is allocated represents the lowest level within the
Group at which the goodwill is monitored for internal management
purposes.
The total intangible value in use
for each CGU, incorporating goodwill and the intangible asset
value, is determined using discounted cash flow projections derived
from the total historical revenue profile of each identifiable CGU.
The assumptions which are applied to each CGU including the useful
economic life are set out in Note 2.7.
The Directors of the Group now
assess Insig AI Plc as a one whole CGU. This is due to the Group's
revenues not being largely independent of each other. Therefore,
they are not individually identifiable as assets which generate
cash inflows, but instead as a group.
The key assumptions for the value
in use calculations are those regarding growth rates particularly
in respect of the growth in revenue and discount rates. The
discount rate is reviewed annually to take into account the current
market assessment of the time value of money and the risks specific
to the cash generating units and rates used by comparable
companies. The discount rate used to calculate the value in
use is 27.5%. The long term growth rate used for the terminal
value calculation was 2%. Impairments of intangible assets are
sensitive to changes in forecasted revenue and changes in the
discount rate, which are depicted in the tables below. As a result,
management has scrutinised the probable economic benefit of the
intangible assets based on revenue forecasts produced, to apply
appropriate impairments where necessary.
Sensitivity test - Impairments
|
Group
|
|
2024
|
Impact on impairment
|
£
|
+10% Revenue
|
933,000
|
-10% Revenue
|
(933,000)
|
|
Group
|
|
2024
|
Impact on impairment
|
£
|
+5% Discount rate
|
1,209,000
|
-5% Discount rate
|
(1,908,00)
|
The tables above reflect the
sensitivity of the Company's impairments to changes in revenue and
the discount rate. A 10% change in revenue will either increase or
decrease the impairment by £933,000 (depending on if it is an
increase or decrease). A 5% increase in the discount rate increases
the impairment by £1,209,000, and reduces the impairment by
£1,908,000 if the discount rate reduces by 5%.
An impairment review of the
Group's development costs, technology, customer
relationships and database technology is carried out on an annual basis. The recoverable amounts of the cash-generating units
are determined from value in use calculations. The key assumptions
for the value in use calculations are those regarding forecast
revenues, discount rates and operating costs. Management have
considered the following elements:
(i) Based on
current assessments of the Insig Partners activities made by the
Directors, they consider that whilst revenues are forecast to grow
in 2024 and exponentially grow from 2025-2027, these forecasts are
reduced from previous forecasts prepared.
(ii) The
reduction of activities in Insig Data have led to the Directors
assessing the need for an impairment.
(iii) Operational
costs are monitored and controlled
Following their assessment, the
Directors concluded an impairment charge of £15,317,338 (2023:
£16,558,296) was necessary for the year ended 31 March 2024 due to
the reduced future sales forecast following the Company's sales
performance in the current and prior years.
15. Investments in subsidiary
undertakings
|
Company
|
Shares in Group
Undertakings
|
Investment in
subsidiaries
|
Loans to Group
Undertakings
|
Cost
|
|
|
31 March 2023
|
15,594,537
|
4,788,599
|
Additions
|
-
|
217,535
|
Impairment
|
(15,594,537)
|
-
|
31 March 2024
|
-
|
5,006,134
|
|
Company
|
Shares in Group Undertakings and
Group Loans
|
NBV 31 March 2024
£
|
NBV 31 March 2023
£
|
Cost
|
|
|
Insig Partners
|
-
|
15,594,537
|
Insig Data
|
-
|
-
|
Loans to Group
undertakings
|
4,075,827
|
4,788,599
|
Total
|
4,075,827
|
20,383,136
|
Investments in Group undertakings
are stated at cost, which is the fair value of the consideration
paid, less any impairment provision.
Although Insig Data's trading
activity remained stagnant during the year, it hasn't ceased its
trade.
The Company has provided a
guarantee in respect of the outstanding liabilities of the
subsidiary companies listed below in accordance with Section 479A -
479C of the Companies Act 2006 as these subsidiary companies of the
Group are exempt from the requirements of the Companies Act 2006
relating to the audit of the accounts by virtue of Section 479A of
this Act.
During the year, £15,594,537 of
the investment held in Insig Partners was impaired after review
from Management. This impairment was determined after comparing the
total investment value of £15,594,537 with the value in use total.
There was also an impairment of the intangible assets held within
Insig Partners. This was applied as a result of a revised forecast
dated from March 2024 to March 2030. The revised sales expected for
the Company's products and cost base led to a reduced enterprise
value of Insig Partners' intangible assets.
During the year, the loans granted
to Insig Partners by Insig AI plc were partially impaired by
£930,307. These impairments were agreed based on the recoverability
of the loans, after taking the net assets of the subsidiary into
account.
Subsidiaries
The following companies were
subsidiaries at the balance sheet date and the results and year end
position of these companies have been included in these
consolidated financial statements.
Name of subsidiary
|
Registered office address
|
Country of incorporation and place of
business
|
Proportion of ordinary shares held (%)
|
Nature of business
|
Insig Partners Limited
|
6 Heddon Street, London, W1B
4BT
|
United Kingdom
|
100%
|
Artificial Intelligence
|
Westside Sports Limited
|
6 Heddon Street, London, W1B
4BT
|
United Kingdom
|
100%
|
Holding company
|
Insight Capital Consulting
Limited**
|
6 Heddon Street, London, W1B
4BT
|
United Kingdom
|
100%
|
Artificial Intelligence
|
Insig Data Limited
|
6 Heddon Street, London, W1B
4BT
|
United Kingdom
|
100%
|
Artificial Intelligence
|
Ultimate Player Limited
|
6 Heddon Street, London, W1B
4BT
|
United Kingdom
|
100%
|
Dormant
|
Pantheon Leisure Plc *
|
6 Heddon Street, London, W1B
4BT
|
United Kingdom
|
85.87%
|
Activities of head
office
|
* Shares held
indirectly through Westside Sports Limited
** Shares held indirectly by Insig
Partners Limited
The data for the disposed
subsidiaries are not included in the balance sheet. The profit and
loss figures for the disposed subsidiaries are included within the
statement of profit and loss, under the "discontinued operations"
heading. This data represents Sport in Schools' and The Elms
Group's performance up to the date of disposal, which was 14
November 2023.
16. Trade and other
receivables
|
Group
|
|
Company
|
Current
|
31 March 2024
£
|
31 March 2023
£
|
|
31 March 2024
£
|
31 March 2023
£
|
Trade receivables
|
77,250
|
125,030
|
|
-
|
-
|
Amounts due from subsidiary
undertakings
|
-
|
-
|
|
230,853
|
106,864
|
Prepayments
|
27,067
|
38,498
|
|
27,067
|
26,749
|
VAT receivable
|
-
|
-
|
|
8,809
|
18,086
|
Research and development
receivable
|
-
|
542,000
|
|
-
|
-
|
Other receivables
|
423
|
14,312
|
|
-
|
-
|
Total
|
104,740
|
719,840
|
|
266,729
|
151,699
|
The ageing of trade receivables is as follows:
|
|
Group
|
|
|
|
As at 31 March 2024
£
|
As at 31 March 2023
£
|
Up to 3 months
|
|
77,250
|
125,030
|
Total
|
|
77,250
|
125,030
|
|
|
Company
|
|
|
|
As at 31 March 2024
£
|
As at 31 March 2023
£
|
Up to 3 months
|
|
-
|
-
|
Total
|
|
-
|
-
|
17. Cash and cash
equivalents
|
Group
|
|
Company
|
|
31 March 2024
£
|
31 March 2023
£
|
|
31 March 2024
£
|
31 March 2023
£
|
Cash at bank and in
hand
|
37,847
|
280,584
|
|
14,459
|
3,749
|
18. Trade and other
payables
|
Group
|
|
Company
|
|
31 March 2024
£
|
31 March 2023
£
|
|
31 March 2024
£
|
31 March 2023
£
|
|
Trade payables
|
139,722
|
266,978
|
|
116,883
|
149,346
|
|
Accruals
|
108,860
|
371,056
|
|
71,735
|
233,290
|
|
Deferred income
|
-
|
50,000
|
|
-
|
-
|
|
Other payables
|
24,482
|
4,852
|
|
1,967
|
-
|
|
Taxes and social
security
|
65,174
|
240,041
|
|
2,264
|
-
|
|
|
338,238
|
932,927
|
|
192,849
|
382,636
|
|
The ageing of trade and other payables is as follows:
|
|
Group
|
|
|
|
As at 31 March 2024
£
|
As at 31 March 2023
£
|
Up to 3 months
|
|
231,637
|
170,849
|
3 to 6 months
|
|
-
|
296,448
|
6 to 12 months
|
|
90,101
|
-
|
Over 12 months
|
|
16,500
|
-
|
Total
|
|
338,238
|
467,297
|
|
|
|
|
|
|
Company
|
|
|
|
|
As at 31 March 2024
£
|
As at 31 March 2023
£
|
|
Up to 3 months
|
|
115,121
|
83,012
|
|
3 to 6 months
|
|
-
|
66,333
|
|
6 to 12 months
|
|
77,726
|
-
|
|
Total
|
|
192,847
|
149,346
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
19. Leases and
borrowings
|
Group
|
Company
|
|
31 March 2024
|
31 March 2023
|
31 March 2024
|
31 March 2023
|
|
£
|
£
|
£
|
£
|
Not later than one year:
|
|
|
|
|
Convertible loan note
|
1,544,324
|
2,261,769
|
1,544,324
|
2,261,769
|
Right of use liability
|
-
|
10,386
|
-
|
-
|
|
|
|
|
|
Later than one year:
|
|
|
|
|
Right of use liability
|
-
|
16,868
|
-
|
-
|
Total
|
1,544,324
|
2,289,023
|
1,544,324
|
2,261,769
|
|
|
|
|
|
20. Convertible loan
notes
|
|
|
|
|
|
CLN 1
|
CLN 2
|
CLN 3
|
31 March 2024
|
|
£
|
£
|
£
|
£
|
|
|
|
|
|
Convertible loan note
|
1,000,000
|
500,000
|
750,000
|
2,250,000
|
Interest
|
|
|
|
|
Accrued interest
|
95,057
|
45,643
|
35,076
|
175,776
|
|
|
|
|
|
Conversion
|
-
|
-
|
(785,076)
|
(785,076)
|
|
|
|
|
|
Modification of convertible loan
note
|
(65,021)
|
(31,355)
|
-
|
(96,376)
|
Total
|
1,030,036
|
514,288
|
-
|
1,544,324
|
Equity
|
|
|
|
|
Amount classified as
equity
|
86,025
|
52,618
|
-
|
138,643
|
Total
|
86,025
|
52,618
|
-
|
138,643
|
|
|
|
|
|
| |
On 4 May 2022, the Company entered
into a formal agreement for a £1.0m convertible loan note to be
provided by Richard Bernstein, Director of the Company. A total of
£1,000,000 has been drawn down by the Company. The loan facility
when issued was originally repayable on or before 31 December 2022,
and interest accrued from the date monies were drawn down at a rate
of 5%. The convertible loan note can be converted at the
noteholder's discretion.
On 17 June 2022, the Company
entered into a convertible loan facility agreement with David Kyte,
a long-term shareholder in the Company for £500,000. A total of
£500,000 has been drawn down by the Company. The loan facility when
issued was repayable on or before 31 December 2022, and interest
accrued from the date monies were drawn down at a rate of 5%. The
convertible loan note can be converted at the noteholder's
discretion.
On 22 December 2022, the Company
agreed revised terms for both the convertible loan note (CLN)
agreements with Richard Bernstein and David Kyte for £1m and £0.5m
respectively.
The following revisions were made
during the year ended 31 March 2023.
- Interest owed on the first CLN will be rolled up into the
loan expiring 31 December 2023, with an interest of 8% per
annum.
- A conversion price of 20 pence for Richard Bernstein, and 18
pence for David Kyte.
- The issuance of 1,666,667 warrants expiring on 31 December
2025 exercisable at a price of 30 pence for Richard
Bernstein.
- The issuance of 1,388,889 warrants expiring on 31 December
2025 exercisable at a price of 25 pence for David Kyte.
-
The revisions for the year ended
31 March 2024 are as follows:
On 20 December 2023, it was agreed
that the terms of the CLN with David Kyte will be extended by six
months to 30 June 2024, and the interest rate was changed from 8%
per annum to 12% per annum.
On the 12 September 2022, the
Company entered into a formal agreement for a £750,000 convertible
loan note to be provided by Richard Bernstein, Director of the
Company. A total of £750,000 has been drawn down by the
Company.
The loan facility is repayable on
or before 30 June 2023, and interest will be accrued from the date
monies are drawn down
at a rate of 5%. The loan facility
has a conversion price which is set at the higher of 35 pence per
ordinary share or the prevailing share price at the date of
conversion. The convertible loan note can be converted at the
noteholder's discretion.
On 14 December 2023, it was agreed
that the terms of the CLN with Richard Bernstein will be extended
by six months to 30 June 2024. All other terms of the agreement
remained the same.
On 15 November 2023, the Company
received notice from Richard Bernstein to convert the balance of
the agreement entered on 12 September 2022 to 3,925,380 ordinary
shares at a conversion price of 20 pence per share. The total
amount converted, including interest, was £785,076.
21. Deferred tax
An analysis of the deferred tax
liability is set out below.
|
|
|
|
|
|
|
|
Cost
£
|
Deferred tax liability
|
|
|
|
|
As at 31 March 2022
|
|
|
|
4,160,088
|
Deferred tax liability for
intangibles
|
|
|
|
(1,573,992)
|
As at 31 March 2023
|
|
|
|
2,586,096
|
Deferred tax liability for
intangibles
|
|
|
|
(1,485,096)
|
As at 31 March 2024
|
|
|
|
1,101,000
|
22. Financial Instruments by
Category
Group
|
31 March 2024
|
31 March 2023
|
|
Amortised cost
|
Total
|
Amortised cost
|
Total
|
Financial Assets per Statement of Financial
Position
|
£
|
£
|
£
|
£
|
Trade and other
receivables
|
77,673
|
77,673
|
681,341
|
681,341
|
Cash and cash
equivalents
|
37,847
|
37,847
|
280,584
|
280,584
|
|
115,520
|
115,520
|
961,925
|
961,925
|
|
|
|
|
31 March 2024
|
31 March 2023
|
|
Amortised cost
|
Total
|
Amortised cost
|
Total
|
Financial Liabilities per Statement of Financial
Position
|
£
|
£
|
£
|
£
|
Trade and other
payables
|
1,792,907
|
1,792,907
|
2,964,025
|
2,964,025
|
Right of use lease
liabilities
|
-
|
-
|
27,254
|
27,254
|
|
1,792,907
|
1,792,907
|
2,991,279
|
2,991,279
|
|
|
|
|
| |
The convertible loan notes
provided during the year by Richard Bernstein and David Kyte have
been included in the payables as they are classed as financial
liabilities.
Company
|
31 March 2024
|
31 March 2023
|
|
Amortised cost
|
Total
|
Amortised cost
|
Total
|
Financial Assets per Statement of Financial
Position
|
£
|
£
|
£
|
£
|
Trade and other
receivables
|
230,852
|
230,852
|
106,864
|
106,864
|
Due from subsidiary
undertakings
|
4,075,827
|
4,075,827
|
4,788,599
|
4,788,599
|
Cash and cash
equivalents
|
14,459
|
14,459
|
3,749
|
3,749
|
|
4,321,138
|
4,321,138
|
4,899,212
|
4,899,212
|
|
31 March 2024
|
31 March 2023
|
|
|
Amortised cost
|
Total
|
Amortised cost
|
Total
|
Financial Liabilities per Statement of Financial
Position
|
£
|
£
|
£
|
£
|
|
Trade and other
payables
|
192,849
|
192,849
|
382,636
|
382,636
|
|
|
192,849
|
192,849
|
382,636
|
382,636
|
|
The Company's financial
instruments comprise cash and cash equivalents, receivables and
payables which arise in the normal course of business. As a result,
the main risks arising from the Company's financial instruments are
credit and liquidity risks. Please refer to Note 3.1
share capital and premium.
Group and Company
|
Number of shares
|
Share capital
|
|
31 March
2024
|
31 March
2023
|
31 March 2024
|
31 March 2023
|
Ordinary shares
|
109,601,025
|
105,675,645
|
1,841,833
|
1,056,757
|
Deferred shares
|
22,811,638
|
22,811,638
|
2,053,047
|
2,053,047
|
Total
|
132,412,663
|
128,487,283
|
3,894,880
|
3,109,804
|
|
|
|
|
| |
Issued at 0.01 pence per share
|
Number of Ordinary shares
|
Share capital
£
|
Share premium
£
|
Total
£
|
As at 31 March 2023
|
105,675,645
|
1,056,756
|
39,077,403
|
40,134,159
|
24 April 2023 - Equity subscription from treasury
reserve
|
-
|
-
|
900,000
|
900,000
|
15 November 2023 - Loan conversion
|
3,925,380
|
39,254
|
745,822
|
785,076
|
27 November 2023 - Issue of shares from treasury
reserve
|
-
|
-
|
87,500
|
87,500
|
As at 31 March 2024
|
109,601,025
|
1,096,010
|
40,810,725
|
41,906,735
|
As at 31 March 2024, The Company
had 505,888 shares held in treasury. The number of ordinary shares
presented are the number of ordinary shares before taking the
treasury reserve into account.
On 24 April 2023, the Company
raised £0.9 million by way of equity subscription. 5,294,118 shares
were issued at 17 pence per share from the Company's treasury
reserve.
On 28 September 2023, the Company
agreed to issue 500,000 ordinary shares from treasury to John
Wilson for adviser services provided.
On 15 November 2023, Richard
Bernstein converted the balance of the convertible loan, being
£785,076 into 3,925,380 ordinary shares at a conversion price of 20
pence per share.
On 27 November 2023, the Company
agreed to issue 500,000 ordinary shares from treasury to Roger
Parry for the corporate development adviser services
provided.
On 28 November 2023, the Company
agreed to issue 200,000 ordinary shares from treasury to Gareth
Evans for investor relations services provided.
Deferred Shares (nominal value of 0.09 pence per
share)
|
Number of Deferred shares
|
Share capital
£
|
As at 31 March 2023
|
22,811,638
|
2,053,047
|
As at 31 March 2024
|
22,811,638
|
2,053,047
|
The Company has an authorised
share capital limit in place, which will be considered by
shareholders at the next annual general meeting.
23. Share based
payments
The Company has established a
share option scheme for Directors, employees and consultants to the
Group. Share options and warrants outstanding and exercisable at
the end of the period have the following expiry dates and exercise
prices:
|
|
|
|
|
|
Grant Date
|
Vesting Date
|
Expiry Date
|
Exercise price in £ per share
|
|
31 March 2024
|
Options & Warrants
|
|
|
|
|
|
Opening balance
|
|
|
|
|
10,027,138
|
|
|
|
|
|
|
1 August 2019
|
31 January 2020
|
31 July 2023
|
0.20
|
|
(666,666)
|
1 August 2019
|
31 July 2021
|
31 July 2023
|
0.20
|
|
(333,334)
|
1 August 2019
|
31 July 2020
|
31 January 2024
|
0.40
|
|
(333,334)
|
1 August 2019
|
31 July 2021
|
31 January 2024
|
0.40
|
|
(666,666)
|
|
|
|
|
|
8,027,138
|
The Company and Group have no
legal or constructive obligation to settle or repurchase the
options or warrants in cash.
During the year, a total of
2,000,000 options expired.
Warrants
|
2024
|
|
2023
|
Outstanding at beginning of period
|
3,452,138
|
|
396,582
|
Exercised
|
-
|
|
-
|
Vested
|
-
|
|
3,055,556
|
Outstanding as at period end
|
3,452,138
|
|
3,452,138
|
Exercisable at period end
|
3,452,138
|
|
3,452,138
|
The movements in the weighted
average exercise price of the warrants were as follows:
|
2024
|
|
2023
|
Outstanding at beginning of period
|
0.46
|
|
0.84
|
Granted
|
-
|
|
0.28
|
Outstanding as at period end
|
0.46
|
|
1.12
|
Exercisable at period end
|
0.46
|
|
0.46
|
In accordance with IFRS2, the fair
value of the warrants issued and recognised as a charge in the
accounts for the 12 month period is nil (31 March 2023 - £Nil). In
arriving at this amount, the expected volatility is based on
historical volatility, the expected life is the average expected
period to exercise, and the risk-free rate of return is the yield
on a zero-coupon UK government bond for a term consistent with the
assumed option life.
The fair value of the equity
instruments granted was determined using the Black Scholes Model.
The inputs into the model for warrants outstanding at the year-end
were as follows
|
2022 Warrants
|
Granted on:
|
22 December 2022
|
Life (years)
|
3 years
|
Share price (pence per
share)
|
15p
|
Exercise price
|
25p
|
Shares under option
|
3,055,556
|
Vesting period (years)
|
3 years
|
Small company discount
factor
|
20%
|
Total fair value (pence per
option)
|
0.33
|
Options
In January 2011, the Company
adopted an unapproved share option scheme and on 1 August 2019, the
Company granted options over 4,000,000 ordinary shares in the
Company as part of a Director's compensation agreement. In March
2022, the Company granted options over 3,350,000 ordinary shares to
a Director and certain employees. No options were granted in the
year ended March 2023 and 2024. Details of the options are set out
below:
|
2024
|
|
2023
|
|
Outstanding at beginning of period
|
6,575,000
|
|
7,350,000
|
|
Lapsed during period
|
(2,000,000)
|
|
(775,000)
|
|
Exercised
|
-
|
|
-
|
|
Granted
|
-
|
|
-
|
|
Outstanding as at period end
|
4,575,000
|
|
6,575,000
|
|
Exercisable at period end
|
2,000,000
|
|
4,000,000
|
|
|
2024
|
|
2023
|
Outstanding at beginning of period
|
44.0
|
|
46.0
|
Lapsed
|
30.0
|
|
48.0
|
Exercised
|
-
|
|
-
|
Granted
|
-
|
|
-
|
Outstanding as at period end
|
53.0
|
|
44.0
|
Exercisable at period end
|
53.0
|
|
44.0
|
|
|
|
|
|
|
| |
The movements in the weighted
average exercise price of the options were as follows:
The fair value of the equity
instruments granted was determined using the Black Scholes Model.
The only conditions attached to the options is continuing
employment. The inputs into the model for options outstanding at
the year-end were as follows:
|
2022 Options
|
Granted on:
|
8 March 2022
|
Life (years)
|
10 years
|
Share price (pence per
share)
|
27.5p
|
Exercise price
|
48p
|
Shares under option
|
3,350,000
|
Risk free rate
|
0.57%
|
Expected volatility
|
43.1%
|
Vesting period (years)
|
8 to 9 years
|
Small company discount
factor
|
35%
|
Total fair value (pence per
option)
|
0.02
|
The expected volatility is based
on historical volatility, the expected life is the average expected
period to exercise, and the risk-free rate of return is the yield
on a zero-coupon UK government bond for a term consistent with the
assumed option life.
In accordance with IFRS 2, the
fair value of the share options issued and recognised as a charge
in the accounts for the 12 month period is £nil (2023:
£nil).
The weighted average contractual
life of options outstanding on 31 March 2024 was 5 years (2023: 4.3
years).
24. Other reserves
|
|
|
|
Equity reserve for convertible loan notes
|
Merger reserve
£
|
Total
£
|
At 31 March 2023
|
51,798
|
325,583
|
377,381
|
Equity element arising on the
issue of convertible loan notes
|
138,634
|
-
|
138,634
|
At 31 March 2024
|
190,432
|
325,583
|
516,015
|
25. Directors'
remuneration
|
|
31 March 2024
|
|
|
Salary or Fees
|
Pension
|
Total
|
|
|
£
|
£
|
£
|
|
Executive Directors
|
|
|
|
|
Richard Bernstein
|
35,000
|
-
|
35,000
|
|
Steven Cracknell
|
156,000
|
10,000
|
166,000
|
|
Warren Pearson
|
178,643
|
10,000
|
188,643
|
|
Colm McVeigh
|
150,000
|
6,000
|
156,000
|
|
Non-executive Directors
|
|
|
|
|
John Murray
|
2,917
|
-
|
2,917
|
|
Richard Cooper*
|
12,000
|
-
|
12,000
|
|
|
534,560
|
26,000
|
560,560
|
|
|
|
|
|
| |
*Richard Cooper is a director of
Luclem Estates & Advisory Limited which received £32,873 in
fees in the year to 31 March 2024.
Directors who retired after the
year end:
· John Murray - deceased 24 April 2023
· Colm McVeigh - resigned 29 May 2024
· Warren Pearson - resigned as director 29 May 2024
Of the above Group directors'
remuneration, £308,911 (31 March 2023: £288,665) has been
capitalised in accordance with IAS 38 as development related costs
and are shown as an intangible addition in the year. None of the
settlement fees were capitalised.
|
|
31 March 2023
|
|
|
Salary
|
Pension
|
Total
|
|
|
£
|
£
|
£
|
|
Executive Directors
|
|
|
|
|
Richard Bernstein
|
35,000
|
-
|
35,000
|
|
Steven Cracknell
|
146,667
|
10,000
|
156,667
|
|
Warren Pearson
|
146,667
|
10,000
|
156,667
|
|
Colm McVeigh
|
233,333
|
9,333
|
242,666
|
|
Non-executive Directors
|
|
|
|
|
John Murray
|
35,000
|
-
|
35,000
|
|
Richard Cooper*
|
12,000
|
-
|
12,000
|
|
|
608,667
|
29,333
|
638,000
|
|
|
|
|
|
| |
*Richard Cooper is a director of Luclem Estates & Advisory
Limited which received £31,826 in fees in the year to 31 March
2024.
The remuneration of Directors and
key executives is determined by the remuneration committee having
regard to the performance of individuals and market
trends.
26. Income tax expense
|
Group
|
|
Year ended
31 March 2024
£
|
Year ended
31 March 2023
£
|
Current Tax
|
|
|
UK corporation tax on profit for
the year
|
(117,043)
|
(542,000)
|
Adjustments in respect of prior
periods
|
(13,290)
|
(749,873)
|
Total current tax
|
(130,333)
|
(1,291,873)
|
Deferred Tax
|
|
|
Intangibles on business
combinations
|
(1,485,096)
|
(1,573,992)
|
Total deferred tax
|
(1,485,096)
|
(1,573,992)
|
Total income tax expense
|
(1,615,429)
|
(2,865,865)
|
|
Group
|
|
Year ended
31 March 2024
£
|
Year ended
31 March 2023
£
|
Loss before tax
|
(17,571,318)
|
(21,428,211)
|
Tax at the applicable rate of
25% (2023:
25%)
|
(4,392,830)
|
(4,071,360)
|
Effects of:
|
|
|
Expenditure not deductible for tax
purposes
|
3,048,662
|
2,940,457
|
Income not taxable for tax
purposes
|
(65,462)
|
-
|
Adjustments in respect of prior
periods - current tax
|
(13,290)
|
-
|
Adjustments in respect of prior
periods - deferred tax
|
-
|
-
|
Additional deduction for R&D
expenditure
|
-
|
(401,421)
|
Surrender of tax losses for
R&D tax credit refund
|
-
|
168,207
|
R&D expenditure
credits
|
-
|
8,461
|
Group relief
surrendered/(claimed)
|
(13,335)
|
(20,948)
|
Adjustments in respect of prior
periods regarding R&D
|
-
|
(749,873)
|
Effect of tax rate change on
deferred tax opening balance
|
-
|
(209,040)
|
Unrecognised deferred tax asset in
relation to carried forward losses
|
(179,174)
|
(530,348)
|
Tax charge
|
(1,615,429)
|
(2,865,865)
|
The Group has unutilised tax
losses of approximately £14,545,091 (31 March 2023 £13,828,392)
available to carry forward against future taxable profits. No
deferred tax asset has been recognised on accumulated tax losses
because of uncertainty over the timing of future taxable profits
against which the losses may be offset.
27. Earnings/Loss per
share
Continued Operations
The calculation of the total basic
loss per share of 17.71 pence
(31 March 2023: 17.89 pence) is based on the loss
attributable to equity holders of the parent company's continued
operations of £16,120,188
(31 March
2023: £18,568,591) and on the weighted average number
of ordinary shares of 100,155,706
(31 March
2023: 103,757,837) in issue during the
year.
Discontinued Operations
The calculation of the total basic
earnings per share of 0.21 pence (31 March 2023: 0.01
pence) is based on the
earnings attributable to equity holders of the parent company's
discontinued operations of £210,085
and on the weighted average number of ordinary
shares of 100,155,706 (31 March 2023: 103,757,837) in issue during the year.
In accordance with IAS 33, basic
and diluted loss per share are identical for the Group as the
effect of the exercise of share options would be to decrease the
loss per share. Details of share options that could potentially
dilute earnings per share in future periods are set out in Note
24.
28. Contingent
Liabilities
The Group had a contingent liability
as at 31 March 2024 in respect of a Research & Development Tax
Credit of £117,042 (2023: £nil) received from HM Revenue &
Customs ("HMRC"). The Tax Credit, which relates to the year ended
31 March 2023 tax return, was recognised in the financial
statements as an asset as at 31 March 2023 and was received from
HMRC during the year ended 31 March 2024. HMRC provided a notice of
enquiry in January 2024 and opened an enquiry in relation to the
balance. The enquiry remained open at the year end and the Group is
in ongoing discussions regarding the enquiry post year end. The
full balance of £117,042 is included in the enquiry and is
therefore the total estimated value included as a contingent
liability, however the Group is confident in defending the full
value of the Tax Credit.
29. Discontinued
Operations
On 14 November 2023, the Company's
85.87% owned subsidiary, Pantheon Leisure plc ("Pantheon"), entered
into a sale agreement for Sports in Schools and Elms Group with
Haygreen Limited for a total cash consideration payable of
£300,000. The disposed subsidiaries are reported in the financial
statements as discontinued operations. Financial information
relating to the discontinued operations from 1 April 2023 to the
date of disposal are set out below.
The financial performance and cash
flow information are for the period ended 14 November
2023.
Financial performance and cash flow
information
|
|
November 2023
£
|
|
|
|
Revenue
|
|
928,807
|
Net expenses
|
|
(883,022)
|
Gain on disposal
|
|
164,300
|
Profit before income tax
|
|
210,085
|
Profit for the year from discontinued
operations
|
|
210,085
|
|
|
|
Net cash used in operating
activities
|
|
(58,319)
|
Net cash generated from
investing
|
|
138,572
|
Net cash used in
financing
|
|
(261,847)
|
Net increase in cash and cash equivalents
|
|
(181,594)
|
Details of the sale of the
subsidiaries
|
|
|
|
November 2023
£
|
|
|
|
|
|
Consideration received or
receivable:
|
|
|
|
|
Cash
|
|
|
|
300,000
|
Total disposal consideration
|
|
|
|
300,000
|
Carrying amount of net assets sold
(see below)
|
|
|
|
(74,500)
|
Disposal fee
|
|
|
|
(1,200)
|
Loss of goodwill after
disposal
|
|
|
|
(60,000)
|
Profit on disposal of subsidiaries
|
|
|
|
164,300
|
The carrying amounts of assets and
liabilities as at the date of sale (14 November 2023)
were:
|
|
|
|
November2023
£
|
|
|
|
|
|
Property, plant and
equipment
|
|
|
|
7,830
|
Cash
|
|
|
|
111,596
|
Right of use asset
|
|
|
|
21,785
|
Trade and other
receivables
|
|
|
|
170,494
|
Total assets
|
|
|
|
311,705
|
Trade and other
payables
|
|
|
|
(237,205)
|
Total liabilities
|
|
|
|
(237,205)
|
Net Assets disposed
|
|
|
|
74,500
|
|
|
|
|
|
30. Related party
transactions
Loans to Group undertakings
Amounts receivable as a result of
loans granted to subsidiary undertakings are as follows:
|
Company
|
|
31 March 2024
|
31 March 2023
|
|
£
|
£
|
Insig Partners
|
4,404,000
|
4,655,904
|
Insig Data
|
42,113
|
-
|
Insight Capital Consulting
Limited
|
184
|
31
|
Pantheon Leisure Plc
|
(370,470)
|
132,664
|
Westside Sports Limited
|
-
|
-
|
|
4,075,827
|
4,788,599
|
Insig Partners Limited
Loans totalling £678,402 were
provided to Insig Partners Limited from Insig AI Plc during the
year to cover operating costs (31 March 2023:
£1,322,635).
During the year, the loan balance
owed by Insig Partners was impaired by £930,306 to £4,404,000, to
reflect the value of the investment that is held within the
subsidiary as at 31 March 2024.
Insig Data Limited (formerly FDB Systems
Limited)
Loans totalling £42,113 were
provided to Insig Data from Insig AI Plc during the year to cover
operating costs (31 March 2023: £291,761).
Insight Capital Consulting Limited
Loans totalling £153 were provided
to Insight Capital Consulting from Insig Partners Limited during
the year to cover operating costs (31 March 2023: £31).
Pantheon Leisure Plc
Loans totalling £5,666 were
provided to Pantheon Leisure from Insig AI Plc during the year to
cover operating costs (31 March 2023: £2,121).
The proceeds and dividends due to
be received by Pantheon Leisure after the disposal of Sport in
Schools and The Elms Group in November 2023 totalled £508,800. The
proceeds were deposited in Insig AI Plc's bank account and the
£210,000 dividends were applied against Pantheon's intercompany
balance with Insig AI.
All intra Group transactions are
eliminated on consolidation.
Other transactions
The Group defines its key
management personnel as the Directors of the Company as disclosed
in the Directors' Report.
Luclem Estates Limited, a company
of which Richard Cooper is a director, was paid a fee of £25,638
the year ended 31 March 2024 (31 March 2023: £32,112) for the
provision of corporate management and consulting services to the
Company. There was a balance of £7,235 owing at year end (31 March
2023: £7,362).
On 24 April 2023, the Company
raised £0.9 million by way of equity subscription for 5,294,118
ordinary shares of 1 pence each in the Company (at 17 pence per
Ordinary Share. As part of this subscription, Richard Bernstein
subscribed for 874,509 shares at 17 pence per share.
On 4 July 2023 the Company
agreed revised terms for a convertible loan note agreement with
Richard Bernstein as announced on 12 September 2022 for £0.75m. The
Company and Richard Bernstein agreed to extend the term of the CLN
by six months to 30 December 2023. All other terms were
unchanged.
On 15 November 2023, the Group
disposed of Sport in School Limited and Elms Group Limited.
Following the Disposal, an existing convertible loan between the
Company and Richard Bernstein was revised. This included the
release of security over Westside Sports Limited and a new
conversion price of 20.0 pence per ordinary share of 1 pence each
in the Company being a 21.2 per cent. premium to the closing price
on 14 November 2023.
31. Ultimate controlling
party
The Directors believe there is no
ultimate controlling party.
32. Events after the reporting date
On 4 April 2024, the Group agreed
to a £250,000 equity funding facility with Richard Bernstein, who
is now the Chief Executive Officer of Insig AI. The facility allows
him to subscribe for up to 1,250,000 new ordinary shares at a price
of 20 pence per share until 31 August 2024.
On 30 May 2024, Colm McVeigh
stepped down from the Board from his role as CEO to pursue other
opportunities. Warren Pearson also stepped down from the Board, but
remains as a full-time employee to focus on product development.
John Wilson was appointed as Non-Executive chairman with immediate
effect.
On 30 May 2024, the Group acquired
5.45% equity interest in ImpactScope OU, an award-winning AI and
blockchain company based in Estonia. The consideration is through
the issue of 900,000 ordinary shares at a price of 13.75 pence per
share. ImpactScope also appointed Insig AI as its exclusive agent
for global sales of their award-winning Greenwashing
Identifier.
On 5 June 2024 the Company raised
£0.813 million via an equity subscription for 6,500,000 shares at a
price of 12.5 pence per share.
On 5 June 2024, the Company
granted share options over 7,800,000 ordinary shares of 1 pence
each in the Company to certain Directors and employees with an
expiry date of 5 June 2029.
On 3 July 2024, Richard Bernstein
and David Kyte extended the redemption dates of their existing
convertible loan notes (CLN) with the Company to 30 September 2025.
Richard agreed to reduce the interest on the CLN to 6% per annum.
The 12% interest on David Kyte's CLN remains unchanged.
END